10-Q: Chicago Atlantic Q3 Profit Drops 20% Amid Rising Credit Loss Provisions
Quarterly Report
Chicago Atlantic Real Estate Finance, Inc. reported a 20% decline in net income for Q3 2025, driven by increased credit loss provisions and a lower portfolio yield, despite a slight increase in its loan portfolio balance.
Summary
- Net income for the three months ended September 30, 2025, decreased by 20% to $8.9 million, compared to $11.2 million in the prior year period.
- Basic earnings per common share fell to $0.42 for Q3 2025, down from $0.57 in Q3 2024.
- Net interest income for Q3 2025 was $13.7 million, a 5% decrease from $14.5 million in Q3 2024.
- Total expenses surged by 46% to $4.8 million in Q3 2025, primarily due to a $1.5 million increase in the provision for current expected credit losses.
- For the nine months ended September 30, 2025, net income decreased by 4% to $27.9 million, from $29.1 million in the same period last year.
- The weighted average portfolio yield decreased to 16.5% as of September 30, 2025, from 18.2% as of September 30, 2024.
- The current expected credit loss (CECL) reserve increased to $5.0 million as of September 30, 2025, representing 1.25% of loans held for investment, up from $4.3 million (1.06%) at December 31, 2024.
- Two loans, Loan #9 and Loan #6, with a combined carrying value of $23.9 million, were on non-accrual status as of September 30, 2025.
- The Revolving Loan maturity date was extended from June 30, 2026, to June 30, 2028, on August 5, 2025.
- The At-the-Market (ATM) Offering Program maximum size was increased to $100.0 million from $75.0 million in March 2025, with commissions reduced to 2.0% from 3.0%.
Sentiment
Score: 4
Explanation: The sentiment is moderately negative due to significant declines in net income and EPS, coupled with a substantial increase in credit loss provisions and a decrease in portfolio yield. While there are some positive operational developments like debt maturity extensions and capital raise program expansion, the core financial performance metrics indicate a challenging period and increased risk perception.
Positives
- The Revolving Loan's contractual maturity date was extended by two years, from June 30, 2026, to June 30, 2028, providing enhanced liquidity and financial flexibility.
- A related party loan (Vireo Growth, Inc.) with an aggregate principal balance of approximately $54.9 million was fully repaid during Q3 2025, generating $0.9 million in prepayment fee income.
- The At-the-Market (ATM) Offering Program was expanded to $100.0 million, and sales commissions were reduced from 3.0% to 2.0%, potentially lowering future capital raising costs.
- Cash and cash equivalents increased to $28.9 million as of September 30, 2025, from $26.4 million at December 31, 2024.
- The company remains in compliance with all financial covenants for both the Revolving Loan and Unsecured Notes.
Negatives
- Net income for the three months ended September 30, 2025, decreased by 20% year-over-year to $8.9 million.
- Basic earnings per common share declined to $0.42 in Q3 2025 from $0.57 in Q3 2024.
- Net interest income decreased by 5% in Q3 2025, primarily due to a lower weighted average portfolio yield (16.5% vs 18.2%) and a 75 basis point prime rate decline.
- Total expenses increased significantly by 46% in Q3 2025, largely driven by a $1.5 million increase in the provision for current expected credit losses.
- The CECL reserve increased to $5.0 million (1.25% of loans) as of September 30, 2025, from $4.3 million (1.06%) at December 31, 2024, indicating higher perceived credit risk.
- Two loans (Loan #9 and Loan #6) with a carrying value of $23.9 million are on non-accrual status as of September 30, 2025, indicating potential collection issues.
- Loans held for investment risk-rated '4' (high risk/potential for loss) increased to $40.5 million (10.2% of portfolio) as of September 30, 2025, from $38.0 million at December 31, 2024.
Risks
- Exposure to interest rate risk due to fluctuations in Prime Rate and SOFR, potentially leading to increased borrowing costs not matched by fixed-rate earnings or fully by floating-rate earnings.
- Interest rate cap risk on floating-rate assets, where borrowing costs can increase without limitation while asset yields are capped, potentially reducing net interest income or causing losses.
- Credit risk associated with loans, particularly those to relatively new and/or small companies and those operating in the cannabis industry, which involves significant federal illegality risks and potential inability to renew licenses.
- Inability to take possession of cannabis-related collateral in default scenarios due to state laws, potentially leading to losses if loans cannot be sold or real estate cannot be re-purposed.
- Reliance on third-party valuations and probability-weighted models for CECL reserve estimation, which are subjective and may not accurately predict actual credit losses.
- Concentration risk with the top three borrowers representing approximately 27.5% of principal outstanding as of September 30, 2025.
- Commercial real estate loans are subject to volatility from national, regional, and local economic conditions, local real estate conditions, and changes in specific industry segments.
- Potential for new laws adverse to the cannabis industry or modification/elimination of current favorable laws, which could impede business growth and materially affect operations.
Future Outlook
The company expects the demand for capital in the cannabis industry to continue increasing as additional states legalize cannabis, providing opportunities for growth. It intends to capitalize on these opportunities by growing its portfolio and expects to raise additional equity and/or debt financing through capital recycling from loan paydowns, repayments, and sales of common stock via its shelf registration statement and ATM program. Management will closely monitor and evaluate the financial and cash flow performance of Loan #9's now operational assets before restoring it to accrual status.
Management Comments
- Management believes it is more likely than not that the remaining outstanding interest receivable prior to the non-accrual date for Loan #6 remains collectible.
- Management will closely monitor and evaluate the financial and cash flow performance of the now operational assets related to Loan #9 before restoring it to accrual status, given the history of non-payment.
- Management's plan to mitigate risks includes monitoring the legal landscape as deemed appropriate, especially concerning state laws pertaining to the cannabis industry.
- Management believes that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders.
Industry Context
The company operates as a commercial mortgage REIT primarily focused on the state-licensed cannabis industry, which is characterized by an imbalance in credit supply and demand from traditional financial institutions due to federal illegality. This environment creates attractive opportunities for non-bank lenders like Chicago Atlantic. The industry is evolving with potential for increased addressable market as more states legalize cannabis. However, it also faces risks from potential changes in state or national laws and enforcement guidelines, which could adversely affect borrowers and the company's ability to grow.
Comparison to Industry Standards
- The company's weighted average portfolio yield of 16.5% (as of Sep 30, 2025) is generally higher than yields seen in traditional commercial real estate lending, reflecting the higher risk and specialized nature of lending to the cannabis industry.
- The CECL reserve representing 1.25% of aggregate loans held for investment (as of Sep 30, 2025) is a key indicator of credit quality, and its increase suggests a more cautious outlook compared to the prior year.
- The presence of two non-accrual loans (Loan #9 and Loan #6) with a combined carrying value of $23.9 million, and $40.5 million in loans risk-rated '4' (high risk/potential for loss), indicates specific credit challenges that may be more pronounced in the nascent and federally restricted cannabis lending sector compared to mature real estate markets.
- The company's strategy of securing loans with real estate, equipment, receivables, and licenses, along with personal or corporate guarantees, is a common practice in high-risk lending environments to mitigate potential losses, similar to how specialized lenders in other emerging or niche markets operate.
Legal Proceedings
- The company is not aware of any material legal claims that could materially impact its business, financial condition, or results of operations as of September 30, 2025.
Related Party Transactions
- The Management Agreement with Chicago Atlantic REIT Manager, LLC was automatically renewed on April 30, 2025.
- Base Management Fees payable were reduced by Outside Fees of $82,500 for Q3 2025 and $219,117 for the nine months ended September 30, 2025.
- Incentive compensation paid to the Manager was $0.3 million for Q3 2025 and $1.7 million for the nine months ended September 30, 2025, a decrease from prior periods due to lower Core Earnings.
- Loans to affiliates of Vireo Growth, Inc. (a related party where REFI's Executive Chairman holds a significant role) were prepaid in full during Q3 2025, resulting in $0.9 million in prepayment fees.
- Loan #9, which remains on non-accrual status, is a related party loan where the Administrative Agent (a related party) completed foreclosure proceedings, and the company now holds a $14.5 million judgment loan and a $2.0 million second lien term loan, with an affiliated co-lender as the new owner of the membership interests.
Stakeholder Impact
- Shareholders: Decreased net income and EPS may negatively impact shareholder returns. The continued regular cash dividend of $0.47 per share provides consistent income, but the sustainability is tied to REIT taxable income. Increased CECL reserve and non-accrual loans indicate higher risk to capital.
- Employees (of the Manager): Stock-based compensation increased, indicating continued incentives. The Management Agreement renewal ensures continued employment for those managing the company's affairs.
- Borrowers: The company continues to originate and fund loans, providing capital to state-licensed cannabis operators. However, increased credit loss provisions and non-accrual status for some loans highlight challenges faced by certain borrowers in the current economic environment.
- Creditors: The extension of the Revolving Loan maturity date to June 30, 2028, provides stability. Compliance with all financial covenants for both the Revolving Loan and Unsecured Notes maintains creditor confidence.
Next Steps
- Continue to monitor and evaluate the financial and cash flow performance of Loan #9's operational assets before restoring it to accrual status.
- Proceed with the ongoing implementation and documentation of augmented internal control procedures related to CECL reporting with the new third-party provider.
- Seek to raise additional equity and/or debt financing to increase liquidity and fund future investments, potentially through the expanded ATM Program or other offerings under the Shelf Registration Statement.
- Actively manage the loan portfolio and monitor the legal landscape for changes in cannabis industry regulations to mitigate risks.
Key Dates
| Date | Description |
|---|---|
| May 1, 2023 | Loan #9 was placed on non-accrual status due to borrower's breach of covenants. |
| June 20, 2023 | Company entered into an At-the-Market Sales Agreement for up to $75.0 million in common stock. |
| August 10, 2023 | Administrative Agent for Loan #9 was the highest bidder in a public auction of membership interests and took ownership. |
| December 2024 | Administrative Agent for Loan #9 was granted a summary judgment of approximately $14.5 million against the borrower credit parties. |
| January 2025 | Court of Common Pleas in Snyder County, Pennsylvania, granted an order in favor of the Agent for Loan #9, recognizing members as owner-operators. |
| February 2025 | Upon PA DOH approval, Agent members satisfied conditions and assumed full control of Loan #9 facilities and operations. |
| March 18, 2025 | Company amended its ATM Program, increasing maximum offering size to $100.0 million and reducing sales commissions to 2.0%. |
| March 31, 2025 | Following foreclosure, the original Loan #9 was extinguished, and the company now holds a $14.5 million judgment loan and a $2.0 million second lien term loan. |
| April 1, 2025 | 187,157 restricted stock awards were granted to employees of the Manager, with a three-year vesting period. |
| April 2025 | Loan #9 borrower opened its three dispensary locations, which were previously non-operational. |
| April 30, 2025 | The Management Agreement was automatically renewed for another one-year period. |
| May 9, 2025 | Loan #6 was placed on non-accrual status due to non-payment of interest and principal. |
| July 8, 2025 | A related party loan held at fair value (approximately $5.5 million outstanding principal) was repaid in full. |
| July 2025 | Company received principal repayments totaling $56.8 million from the full repayment of Loans #3, #20, #29, #32, #33, and #39, recognizing $1.0 million in prepayment fees. |
| July 2025 | Loan #19 was amended, extending its maturity date from December 30, 2025, to December 30, 2027, and included a $2.4 million commitment add-on. |
| August 5, 2025 | The Revolving Loan's contractual maturity date was extended from June 30, 2026, to June 30, 2028. |
| September 30, 2025 | End of the reporting period for the 10-Q filing. |
| October 1, 2025 | Loan #31 was amended, and its maturity date reflects this update. |
| October 15, 2025 | Regular quarterly dividend of $0.47 per common share for Q3 2025 was paid to stockholders of record as of September 30, 2025. |
| November 3, 2025 | Company advanced approximately $3.3 million to existing borrowers and received $0.9 million and $2.3 million in scheduled and unscheduled principal repayments during the period from October 1, 2025, to this date. |
| November 4, 2025 | Filing date of the 10-Q report. |
Recommendation
holdThe company's Q3 2025 results show a notable decline in net income and EPS, primarily driven by a significant increase in the provision for current expected credit losses and a lower weighted average portfolio yield. The increase in non-accrual loans and loans rated as high risk indicates a deteriorating credit quality outlook. While the extension of the Revolving Loan maturity and the expansion of the ATM program provide some operational stability and future capital access, the core profitability metrics are under pressure. For existing investors, holding the stock might be prudent given the consistent dividend and the long-term potential of the cannabis lending market, but new investments should be approached with caution due due to the increased credit risk and reduced profitability. A 'hold' recommendation reflects this cautious stance, acknowledging both the challenges and the company's efforts to manage its debt and capital structure.
Keywords
Commercial Mortgage REIT, Cannabis Industry Lending, Real Estate Finance, SEC 10-Q, Loan Portfolio, Credit Risk, Interest Income, Net Income, CECL Reserve, REIT Taxation, Floating Rate Loans, Unsecured Notes, Revolving Loan, ATM Program
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.